Please use this identifier to cite or link to this item: http://repositorio.unifesp.br/handle/11600/29569
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRequiao-Moura, L. R.
dc.contributor.authorMastroianni-Kirsztajn, G.
dc.contributor.authorMoscoso-Solorzano, G. T.
dc.contributor.authorFranco, M. F.
dc.contributor.authorOzaki, K. S.
dc.contributor.authorPacheco-Silva, A.
dc.contributor.authorCamara, N. O. S.
dc.date.accessioned2016-01-24T12:41:57Z-
dc.date.available2016-01-24T12:41:57Z-
dc.date.issued2007-03-01
dc.identifierhttp://dx.doi.org/10.1016/j.transproceed.2007.01.037
dc.identifier.citationTransplantation Proceedings. New York: Elsevier B.V., v. 39, n. 2, p. 453-456, 2007.
dc.identifier.issn0041-1345
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/29569-
dc.description.abstractIntroduction. Posttransplant glomerulonephritis (GN) is the third cause of graft loss after 1 year of transplant follow-up; few approaches have been efficient in reversing this outcome. the aim of this study was to evaluate whether the modification of the immunosuppressive therapy for treating posttransplant GN had an impact on allograft survival. Patients andMethods. Forty-nine patients who underwent renal transplantation and developed posttransplant GN were divided into two groups: group 1, 22 patients with modified immunosuppressive treatment (72.3%, pulse of methylprednisolone; 13.6%, high-dose oral corticosteroid), and group 2, where it was maintained. Additionally, the impact of the concomitant use of drugs that promote the renin-angiotensin-aldosterone system blockade (RAASB) was analyzed in terms of graft survival.Results. We established the diagnosis of GN at 17.9 months (range, 0.57 to 153.4) after transplantation, when serum creatinine (Cr) was 2.2 mg/dL (range, 0.8 to 12.5) and proteinuria 3.2 g/L (range, 0.2 to 24.2). Graft survivals at 1 and 3 years after diagnosis were 69.2% and 52.9%, respectively. the patients of group 1 showed a lower prevalence of graft loss (27.2% versus 48.1%, P =.40) and better survival at the end of 1 year (73.2% versus 60.4%) and 3 years (62.5% versus 38.0%, P =.26), but the differences were not significant. RAASB showed a positive impact on survival at the end of 3 years in both groups: for group 1, 83.8 % with RAASB, 41.4% without RAASB; and for group 2, 75 % with RAASB and 14.8% without RAASB (P < .001).Conclusion. Although treatment of posttransplant GN with modification of immunosuppression seemed to improve graft survival in the first 3 years after diagnosis, RAASB improved this effect.en
dc.format.extent453-456
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.ispartofTransplantation Proceedings
dc.rightsAcesso restrito
dc.titleImpact of therapeutic changes on renal graft survival with posttransplant glomerulonephritisen
dc.typeArtigo
dc.rights.licensehttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.description.affiliationUniversidade Federal de São Paulo, Clin & Expt Immunol Lab, BR-04023900 São Paulo, Brazil
dc.description.affiliationUniversidade Federal de São Paulo, Glomerulopathies Sect, Div Nephrol, BR-04023900 São Paulo, Brazil
dc.description.affiliationUniversidade Federal de São Paulo, Dept Pathol, BR-04023900 São Paulo, Brazil
dc.description.affiliationUniv São Paulo, Dept Immunol, Lab Transplantat Immunobiol, São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Clin & Expt Immunol Lab, BR-04023900 São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Glomerulopathies Sect, Div Nephrol, BR-04023900 São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Dept Pathol, BR-04023900 São Paulo, Brazil
dc.identifier.doi10.1016/j.transproceed.2007.01.037
dc.description.sourceWeb of Science
dc.identifier.wosWOS:000245344200039
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.